Hypofibrinolysis Is Associated with the Severity of COVID-19 Infection: the Role of Obesity

Basit Öğe Kaydı
dc.authorid0000-0002-3799-4470
dc.authorwosidÇELIKKOL, ALIYE/ABE-2695-2020
dc.contributor.authorOran, Mustafa
dc.contributor.authorAkpınar, Seval
dc.contributor.authorDoğan, Mustafa
dc.contributor.authorAvcı, Burcu Altındağ
dc.contributor.authorÇelikkol, Aliye
dc.contributor.authorTurgut, Burhan
dc.date.accessioned2022-05-11T14:10:14Z
dc.date.available2022-05-11T14:10:14Z
dc.date.issued2021
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları Ana Bilim Dalı
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Ana Bilim Dalı
dc.description.abstractIntroduction: Obesity, by causing hypofibrinolysis and thrombotic complications, ought to be a risk factor in terms of disease severity and mortality in COVID-19 infection. We aim to investigate the effects of obesity on fibrinolytic system in coronavirus patients while studying the changes of major fibrinolytic inhibitors plasminogen activator inhibitor (PAI-1) and thrombin activatable fibrinolysis inhibitor (TAFI). Material and methods: Sixty-six patients and 21 healthy donors were investigated and observed until either their recovery or death. Body mass index (BMI) was calculated for each person and peripheral blood used for PAI-1 and TAFI measurements. PAI-1 antigen and TAFI activated/inactivated (TAFIa/i) were measured using ELISA kits. Results: PAI-1 antigen and TAFIa/i plasma levels are higher in patients than in control group (P<00001 for both). Patients needing ICU had higher TAFIa/i values than non-ICU patients. The 15 patients who died had higher TAFIa/i levels than those staying alive. Obese patients (BMI >= 30) had higher PAI-1 levels than non-obese patients. TAFIa/i is associated with D-dimer, C-reactive protein (CRP), ferritin, creatinine and neutrophile count, whereas PAI-1 is associated only with the serum creatinine level. Conclusion: Our study shows that the levels of the major fibrinolytic inhibitors PAI 1 and TAFI increase in patients with COVID-19 infection, and proves for the first time that PAI 1 levels increase more in obese patients than in non-obese ones. It is also revealed that the plasma TAFI level is associated with the severity of COVID-19 infection, which suggests that the inhibitory treatments against TAFI should be effective in preventing thrombotic complications in the course of COVID-19 infection.
dc.identifier.doi10.19193/0393-6384_2021_4_371
dc.identifier.endpage2382
dc.identifier.issn0393-6384
dc.identifier.issn2283-9720
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85110448887
dc.identifier.scopusqualityN/A
dc.identifier.startpage2377
dc.identifier.urihttps://doi.org/10.19193/0393-6384_2021_4_371
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5336
dc.identifier.volume37
dc.identifier.wosWOS:000673269100071
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthorOran, Mustafa
dc.institutionauthorAkpınar, Seval
dc.institutionauthorDoğan, Mustafa
dc.institutionauthorAvcı, Burcu Altındağ
dc.institutionauthorÇelikkol, Aliye
dc.institutionauthorTurgut, Burhan
dc.language.isoen
dc.publisherCarbone Editore
dc.relation.ispartofActa Medica Mediterranea
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCOVID-19
dc.subjectPlasminogen activator inhibitor-1
dc.subjectThrombin activatable fibrinolysis inhibitor
dc.subjectobesity
dc.subjectPlasminogen-Activator Inhibitor-1
dc.subjectPlasma Procarboxypeptidase-B
dc.subjectNecrosis-Factor-Alpha
dc.subjectFibrinolysis Inhibitor
dc.subjectTafi
dc.subjectExpression
dc.subjectMechanism
dc.subjectTissue
dc.subjectType-1
dc.subjectGene
dc.titleHypofibrinolysis Is Associated with the Severity of COVID-19 Infection: the Role of Obesity
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
5336.pdf
Boyut:
266.98 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu